GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Artiva Biotherapeutics Inc (NAS:ARTV) » Definitions » Change In Receivables

ARTV (Artiva Biotherapeutics) Change In Receivables : $2.77 Mil (TTM As of Sep. 2024)


View and export this data going back to 2024. Start your Free Trial

What is Artiva Biotherapeutics Change In Receivables?

Artiva Biotherapeutics's change in receivables for the quarter that ended in Sep. 2024 was $0.76 Mil. It means Artiva Biotherapeutics's Accounts Receivable declined by $0.76 Mil from Jun. 2024 to Sep. 2024 .

Artiva Biotherapeutics's change in receivables for the fiscal year that ended in Dec. 2023 was $-1.23 Mil. It means Artiva Biotherapeutics's Accounts Receivable increased by $1.23 Mil from Dec. 2022 to Dec. 2023 .

Artiva Biotherapeutics's Accounts Receivable for the quarter that ended in Sep. 2024 was $0.57 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. Artiva Biotherapeutics's liquidation value for the three months ended in Sep. 2024 was $122.46 Mil.

Artiva Biotherapeutics Change In Receivables Historical Data

The historical data trend for Artiva Biotherapeutics's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Artiva Biotherapeutics Change In Receivables Chart

Artiva Biotherapeutics Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
Change In Receivables
- - -0.47 -0.06 -1.23

Artiva Biotherapeutics Quarterly Data
Sep20 Dec20 Mar21 Sep21 Dec21 Mar22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Change In Receivables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.58 1.72 0.04 0.26 0.76

Artiva Biotherapeutics Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $2.77 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Artiva Biotherapeutics  (NAS:ARTV) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Artiva Biotherapeutics's Days Sales Outstanding for the quarter that ended in Sep. 2024 is calculated as:

Days Sales Outstanding
=Accounts Receivable/Revenue*Days in Period
=0.569/0*91
=

2. In Ben Graham's calculation of liquidation value, Artiva Biotherapeutics's accounts receivable are only considered to be worth 75% of book value:

Artiva Biotherapeutics's liquidation value for the quarter that ended in Sep. 2024 is calculated as:

Liquidation Value
=Cash, Cash Equivalents, Marketable Securities-Total Liabilities+(0.75 * Accounts Receivable)+(0.5 * Total Inventories)
=146.631-24.6+0.75 * 0.569+0.5 * 0
=122.46

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Artiva Biotherapeutics Change In Receivables Related Terms

Thank you for viewing the detailed overview of Artiva Biotherapeutics's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.

Artiva Biotherapeutics Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Artiva Biotherapeutics Inc (NAS:ARTV) » Definitions » Change In Receivables
Comparable Companies
FULC CDTX ELDN FDMT LRMR AMLX ITOS CCCC FHTX ACIU VRTX ASX:CSL REGN XKRX:207940 XBRU:UCB XBRU:ARGX ALNY BNTX XKRX:068270 BGNE
Traded in Other Exchanges
N/A
Address
5505 Morehouse Drive, Suite 100, San Diego, CA, USA, 92121
Website
https://www.artivabio.com
Artiva Biotherapeutics Inc is a biopharmaceutical company. The company is engaged in advancing a pipeline of off-the-shelf, allogeneic NK cell therapies for the treatment of hematologic malignancies or solid tumors. The pipeline program of the company includes Artiva-Funded Trials and Collaborator-Funded Trials.